1 |
National Cancer Institute. Metastatic Cancer[Internet]. Place unknown: National Cancer Institute; date unknown[updated 2013 Mar 28; cited 2013 Oct 4] Available from: http://www.cancer.gov/cancertopics/factsheet/Sites-Types/metastatic
|
2 |
Roodman DG. Pathogenesis of myeloma bone disease. Leukemia 2009; 23:435-441.
doi: 10.1038/leu.2008.336
pmid: 19039321
|
3 |
Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001; 27:165-176.
doi: 10.1053/ctrv.2000.0210
pmid: 11417967
|
4 |
Angtuaco EJC, Fassas ABT, Walker R, Sethi R, Barlogie B. Multiple myeloma: clinical review and diagnostic imaging. Radiology 2004; 231:11-23.
doi: 10.1148/radiol.2311020452
pmid: 14990813
|
5 |
George ED, Sadovsky R. Multiple myeloma: recognition and management. Am Fam Physician 1999; 59:1885-1894.
pmid: 10208707
|
6 |
Melton III LJ, Kyle RA, Achenbach SJ, Oberg AL, Rajkumar SV. Fracture risk with multiple myeloma: a population-based study. J Bone Miner Res 2005; 20:487-493.
doi: 10.1359/JBMR.041131
pmid: 15746994
|
7 |
Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 2007; 110:1860-1867.
doi: 10.1002/cncr.22991
pmid: 17763372
|
8 |
Collins CD. Multiple myeloma. Cancer Imaging 2010; 10:20-31.
doi: 10.1102/1470-7330.2010.0013
pmid: 20159661
|
9 |
Winterbottom AP, Shaw AS. Imaging patients with myeloma. Clinical Radiology 2009; 64:1-11.
doi: 10.1016/j.crad.2008.07.006
|
10 |
Aghayev K, Papanastassiou ID, Vrionis F. Role of vertebral augmentation procedures in the management of vertebral compression fractures in cancer patients. Curr Opin Support Palliat Care 2011; 5:222-226.
doi: 10.1097/SPC.0b013e328349652d
pmid: 21734582
|
11 |
Snapper I, Khan A. Myelomatosis: fundamentals and clinical features. Baltimore: University Park Press; 1971.
|
12 |
Edelstyn GA, Gillespie PJ, Grebbell FS. The radiological demonstration of osseous metastases: experimental observations. Clin Radiol 1967; 18:158-162.
doi: 10.1016/s0009-9260(67)80010-2
pmid: 6023348
|
13 |
Kapadia SB. Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases. Medicine (Baltimore) 1980; 59:380-392.
doi: 10.1097/00005792-198009000-00005
|
14 |
He Y, Wheatley K, Clark O, Glasmacher A, Ross H, Djulbegovic B. Early versus deferred treatment for early stage multiple myeloma. Cochrane Database Syst Rev 2003; (1): CD004023.
doi: 10.1002/14651858.CD004023
pmid: 12535504
|
15 |
Moreau P, San Miguel J, Ludwig H, Schouten H, Mohty M, Dimopoulos M, et al. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 Suppl 6: vi 133-137.
doi: 10.1093/annonc/mds250
|
16 |
Attal M, Lauwers-Cances V, Marit G, Caillot D, Moreau P, Facon T, et al. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. N Engl J Med 2012; 366:1782-1791.
doi: 10.1056/NEJMoa1114138
pmid: 22571202
|
17 |
Morgan GJ, Gregory WM, Davies FE, Bell SE, Szubert AJ, Brown JM, et al. The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis. Blood 2012; 119:7-15.
doi: 10.1182/blood-2011-06-357038
|
18 |
Minnema MC, van der Spek E, van de Donk NW, Lokhorst HM. New developments in the treatment of patients with multiple myeloma. Neth J Med 2010; 68:24-32.
pmid: 20103818
|